tanshinone has been researched along with Acute Lung Injury in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, J; Feng, XY; Pu, J; Shang, Y; Xu, JW; Zhang, R; Zhao, JY | 1 |
| Li, P; Liu, J; Wu, YH; Zhang, ZL | 1 |
| Allam, EA; Ashour, AA; El-Kamel, AH; El-Moslemany, RM; Hussein, A; Khalifa, HM | 1 |
| Gan, J; Gao, H; Li, X; Liu, Z; Qiu, H; Yang, S; Yuan, R | 1 |
| Li, J; Li, MX; Liu, YF; Yang, CW; Zheng, Y | 1 |
| Chen, J; Li, Z; Liu, M; Niu, W; Sun, X; Wang, Y; Wu, H | 1 |
| Chen, X; Dai, Y; Fu, L; Lv, Y; Qi, B; Qian, Y; Quan, M | 1 |
| An, XJ; Cao, FL; Jiang, XL; Liu, XZ; Shan, L; Wang, XY; Xu, M; Xu, W; Zhang, YF | 1 |
| Liu, MD; Shen, YH | 1 |
| Cao, FL; Cui, Y; Dong, HY; Dong, MQ; Huang, YF; Li, ZC; Liu, ML; Liu, Y; Luo, Y; Niu, W; Wang, XB; Wang, YX; Xu, M; Zhang, B; Zhao, PT | 1 |
| Cao, FL; Fan, QX; Jin, FG; Li, JH; Li, ZC; Mu, DG; Wang, YX; Xie, XY; Xu, M; Zhang, B; Zhang, Y; Zhao, PT | 1 |
| Cao, F; Cui, Y; Dong, H; Dong, M; Li, Z; Liu, L; Liu, Y; Niu, W; Wang, Y; Xu, D; Xu, M; Zhang, B; Zhao, P | 1 |
12 other study(ies) available for tanshinone and Acute Lung Injury
| Article | Year |
|---|---|
Tanshinone IIA prevents acute lung injury by regulating macrophage polarization.
Topics: Abietanes; Acute Lung Injury; Animals; Cytokine Release Syndrome; Cytokines; Inflammation; Lipopolysaccharides; Macrophage Activation; Macrophages; Mice | 2022 |
Tanshinone IIA improves sepsis-induced acute lung injury through the ROCK2/NF-κB axis.
Topics: Abietanes; Acute Lung Injury; Animals; Inflammation; Lipopolysaccharides; Lung; NF-kappa B; Rats; rho-Associated Kinases; Sepsis | 2022 |
Tanshinone IIA loaded bioactive nanoemulsion for alleviation of lipopolysaccharide induced acute lung injury via inhibition of endothelial glycocalyx shedding.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; COVID-19 Drug Treatment; Gases; Glycocalyx; Lipopolysaccharides; Lung; Rats; Surface-Active Agents; Tea | 2022 |
Total tanshinones protect against acute lung injury through the PLCγ2/NLRP3 inflammasome signaling pathway.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Caspases; Cytokines; Inflammasomes; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Phospholipase C gamma; Reactive Oxygen Species; Signal Transduction; Tumor Necrosis Factor-alpha | 2023 |
Tanshinone IIA alleviates lipopolysaccharide-induced acute lung injury by downregulating TRPM7 and pro-inflammatory factors.
Topics: Abietanes; Acute Lung Injury; Animals; Calcium; Down-Regulation; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Lung; Macrophages; Male; Organ Size; Oxygen; Partial Pressure; Rats, Wistar; Serous Membrane; TRPM Cation Channels; Tumor Necrosis Factor-alpha | 2018 |
Tanshinone IIA attenuates paraquat‑induced acute lung injury by modulating angiotensin‑converting enzyme 2/angiotensin‑(1‑7) in rats.
Topics: Abietanes; Acute Lung Injury; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Biopsy; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Gene Expression; Immunohistochemistry; L-Lactate Dehydrogenase; Male; Neutrophil Infiltration; Paraquat; Peptide Fragments; Peptidyl-Dipeptidase A; Rats | 2018 |
Tanshinone IIA protects against lipopolysaccharide-induced lung injury through targeting Sirt1.
Topics: Abietanes; Acute Lung Injury; Animals; Carbazoles; Cytokines; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; Shock, Septic; Signal Transduction; Sirtuin 1; Transcription Factor RelA | 2019 |
Tanshinone IIA therapeutically reduces LPS-induced acute lung injury by inhibiting inflammation and apoptosis in mice.
Topics: Abietanes; Acute Lung Injury; Animals; Apoptosis; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C | 2015 |
[Effect of Tanshinone II A on Cytokines of Rats with Severe Acute Pancreatitis Lung Injury].
Topics: Abietanes; Acute Lung Injury; Animals; Cytokines; Intercellular Adhesion Molecule-1; Interleukin-1beta; Lung; Pancreatitis; Peroxidase; Rats; Rats, Sprague-Dawley; Taurocholic Acid; Tumor Necrosis Factor-alpha | 2015 |
Tanshinone IIA reduces lethality and acute lung injury in LPS-treated mice by inhibition of PLA2 activity.
Topics: Abietanes; Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Epithelial Cells; Female; Lipopolysaccharides; Lung; Mice; NF-kappa B; Phenanthrenes; Phospholipase A2 Inhibitors; Survival Rate | 2009 |
Tanshinone IIA suppresses lung injury and apoptosis, and modulates protein kinase B and extracellular signal-regulated protein kinase pathways in rats challenged with seawater exposure.
Topics: Abietanes; Acute Lung Injury; Animals; Apoptosis; bcl-Associated Death Protein; Caspase 3; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Oxygen; Partial Pressure; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Seawater | 2011 |
Tanshinone IIA-induced attenuation of lung injury in endotoxemic mice is associated with reduction of hypoxia-inducible factor 1α expression.
Topics: Abietanes; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrier Proteins; Cell Cycle Proteins; DNA-Binding Proteins; Endotoxemia; Eukaryotic Initiation Factors; Hypoxia-Inducible Factor 1, alpha Subunit; Lipopolysaccharides; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Phosphoproteins; Proteasome Endopeptidase Complex; Protein Biosynthesis; Ribosomal Protein S6; Ribosomal Protein S6 Kinases, 70-kDa; Transcription Factors | 2011 |